Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1996 Jun 1;183(6):2635–2644. doi: 10.1084/jem.183.6.2635

HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis

PMCID: PMC2192625  PMID: 8676084

Abstract

To investigate the development of HLA-DR-associated autoimmune diseases, we generated transgenic (Tg) mice with HLA-DRA-IE alpha and HLA-DRB1*0401-IE beta chimeric genes. The transgene-encoded proteins consisted of antigen-binding domains from HLA-DRA and HLA-DRB1*0401 molecules and the remaining domains from the IE(d)-alpha and IE(d)-beta chains. The chimeric molecules showed the same antigen-binding specificity as HLA-DRB1*0401 molecules, and were functional in presenting antigens to T cells. The Tg mice were backcrossed to MHC class II-deficient (IA beta-, IE alpha-) mice to eliminate any effect of endogenous MHC class II genes on the development of autoimmune diseases. As expected, IA alpha beta or IE alpha beta molecules were not expressed in Tg mice. Moreover, cell-surface expression of endogenous IE beta associated with HLA-DRA-IE alpha was not detectable in several Tg mouse lines by flow cytometric analysis. The HLA-DRA-IE alpha/HLA-DRB1*0401-IE beta molecules rescued the development of CD4+ T cells in MHC class II-deficient mice, but T cells expressing V beta 5, V beta 11, and V beta 12 were specifically deleted. Tg mice were immunized with peptides, myelin basic protein (MBP) 87-106 and proteolipid protein (PLP) 175-192, that are considered to be immunodominant epitopes in HLA-DR4 individuals. PLP175-192 provoked a strong proliferative response of lymph node T cells from Tg mice, and caused inflammatory lesions in white matter of the CNS and symptoms of experimental allergic encephalomyelitis (EAE). Immunization with MBP87- 106 elicited a very weak proliferative T cell response and caused mild EAE. Non-Tg mice immunized with either PLP175-192 or MBP87-106 did not develop EAE. These results demonstrated that a human MHC class II binding site alone can confer susceptibility to an experimentally induced murine autoimmune disease.

Full Text

The Full Text of this article is available as a PDF (1.8 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altmann D. M., Douek D. C., Frater A. J., Hetherington C. M., Inoko H., Elliott J. I. The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4. J Exp Med. 1995 Mar 1;181(3):867–875. doi: 10.1084/jem.181.3.867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cammarota G., Scheirle A., Takacs B., Doran D. M., Knorr R., Bannwarth W., Guardiola J., Sinigaglia F. Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules. Nature. 1992 Apr 30;356(6372):799–801. doi: 10.1038/356799a0. [DOI] [PubMed] [Google Scholar]
  3. Cosgrove D., Gray D., Dierich A., Kaufman J., Lemeur M., Benoist C., Mathis D. Mice lacking MHC class II molecules. Cell. 1991 Sep 6;66(5):1051–1066. doi: 10.1016/0092-8674(91)90448-8. [DOI] [PubMed] [Google Scholar]
  4. Endoh M., Tabira T., Kunishita T., Sakai K., Yamamura T., Taketomi T. DM-20, a proteolipid apoprotein, is an encephalitogen of acute and relapsing autoimmune encephalomyelitis in mice. J Immunol. 1986 Dec 15;137(12):3832–3835. [PubMed] [Google Scholar]
  5. Fleury S., Thibodeau J., Croteau G., Labrecque N., Aronson H. E., Cantin C., Long E. O., Sékaly R. P. HLA-DR polymorphism affects the interaction with CD4. J Exp Med. 1995 Sep 1;182(3):733–741. doi: 10.1084/jem.182.3.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fritz R. B., Chou C. H., McFarlin D. E. Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein. J Immunol. 1983 Mar;130(3):1024–1026. [PubMed] [Google Scholar]
  7. Fugger L., Michie S. A., Rulifson I., Lock C. B., McDevitt G. S. Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region beta-chain T-cell repertoire and mediates an HLA-DR-restricted immune response. Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6151–6155. doi: 10.1073/pnas.91.13.6151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Glimcher L. H., McKean D. J., Choi E., Seidman J. G. Complex regulation of class II gene expression: analysis with class II mutant cell lines. J Immunol. 1985 Nov;135(5):3542–3550. [PubMed] [Google Scholar]
  9. Grusby M. J., Johnson R. S., Papaioannou V. E., Glimcher L. H. Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science. 1991 Sep 20;253(5026):1417–1420. doi: 10.1126/science.1910207. [DOI] [PubMed] [Google Scholar]
  10. Hammer J., Belunis C., Bolin D., Papadopoulos J., Walsky R., Higelin J., Danho W., Sinigaglia F., Nagy Z. A. High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations. Proc Natl Acad Sci U S A. 1994 May 10;91(10):4456–4460. doi: 10.1073/pnas.91.10.4456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hammer J., Valsasnini P., Tolba K., Bolin D., Higelin J., Takacs B., Sinigaglia F. Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell. 1993 Jul 16;74(1):197–203. doi: 10.1016/0092-8674(93)90306-b. [DOI] [PubMed] [Google Scholar]
  12. Kawai J., Ando A., Sato T., Nakatsuji T., Tsuji K., Inoko H. Analysis of gene structure and antigen determinants of DR2 antigens using DR gene transfer into mouse L cells. J Immunol. 1989 Jan 1;142(1):312–317. [PubMed] [Google Scholar]
  13. Kuchroo V. K., Collins M., al-Sabbagh A., Sobel R. A., Whitters M. J., Zamvil S. S., Dorf M. E., Hafler D. A., Seidman J. G., Weiner H. L. T cell receptor (TCR) usage determines disease susceptibility in experimental autoimmune encephalomyelitis: studies with TCR V beta 8.2 transgenic mice. J Exp Med. 1994 May 1;179(5):1659–1664. doi: 10.1084/jem.179.5.1659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kuchroo V. K., Das M. P., Brown J. A., Ranger A. M., Zamvil S. S., Sobel R. A., Weiner H. L., Nabavi N., Glimcher L. H. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 1995 Mar 10;80(5):707–718. doi: 10.1016/0092-8674(95)90349-6. [DOI] [PubMed] [Google Scholar]
  15. Lai E., Concannon P., Hood L. Conserved organization of the human and murine T-cell receptor beta-gene families. Nature. 1988 Feb 11;331(6156):543–546. doi: 10.1038/331543a0. [DOI] [PubMed] [Google Scholar]
  16. Lawrance S. K., Karlsson L., Price J., Quaranta V., Ron Y., Sprent J., Peterson P. A. Transgenic HLA-DR alpha faithfully reconstitutes IE-controlled immune functions and induces cross-tolerance to E alpha in E alpha 0 mutant mice. Cell. 1989 Aug 11;58(3):583–594. doi: 10.1016/0092-8674(89)90439-x. [DOI] [PubMed] [Google Scholar]
  17. Lee B. K., Eicher E. M. Segregation patterns of endogenous mouse mammary tumor viruses in five recombinant inbred strain sets. J Virol. 1990 Sep;64(9):4568–4572. doi: 10.1128/jvi.64.9.4568-4572.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Markovic-Plese S., Fukaura H., Zhang J., al-Sabbagh A., Southwood S., Sette A., Kuchroo V. K., Hafler D. A. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J Immunol. 1995 Jul 15;155(2):982–992. [PubMed] [Google Scholar]
  19. Martin R., Jaraquemada D., Flerlage M., Richert J., Whitaker J., Long E. O., McFarlin D. E., McFarland H. F. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J Immunol. 1990 Jul 15;145(2):540–548. [PubMed] [Google Scholar]
  20. Martin R., Utz U., Coligan J. E., Richert J. R., Flerlage M., Robinson E., Stone R., Biddison W. E., McFarlin D. E., McFarland H. F. Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. J Immunol. 1992 Mar 1;148(5):1359–1366. [PubMed] [Google Scholar]
  21. Nabozny G. H., Baisch J. M., Cheng S., Cosgrove D., Griffiths M. M., Luthra H. S., David C. S. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J Exp Med. 1996 Jan 1;183(1):27–37. doi: 10.1084/jem.183.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ota K., Matsui M., Milford E. L., Mackin G. A., Weiner H. L., Hafler D. A. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature. 1990 Jul 12;346(6280):183–187. doi: 10.1038/346183a0. [DOI] [PubMed] [Google Scholar]
  23. Pette M., Fujita K., Wilkinson D., Altmann D. M., Trowsdale J., Giegerich G., Hinkkanen A., Epplen J. T., Kappos L., Wekerle H. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. Proc Natl Acad Sci U S A. 1990 Oct;87(20):7968–7972. doi: 10.1073/pnas.87.20.7968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Pettinelli C. B., Fritz R. B., Chou C. H., McFarlin D. E. Encephalitogenic activity of guinea pig myelin basic protein in the SJL mouse. J Immunol. 1982 Sep;129(3):1209–1211. [PubMed] [Google Scholar]
  25. Pinet V., Vergelli M., Martin R., Bakke O., Long E. O. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature. 1995 Jun 15;375(6532):603–606. doi: 10.1038/375603a0. [DOI] [PubMed] [Google Scholar]
  26. Saito H., Maki R. A., Clayton L. K., Tonegawa S. Complete primary structures of the E beta chain and gene of the mouse major histocompatibility complex. Proc Natl Acad Sci U S A. 1983 Sep;80(18):5520–5524. doi: 10.1073/pnas.80.18.5520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Scherer M. T., Ignatowicz L., Pullen A., Kappler J., Marrack P. The use of mammary tumor virus (Mtv)-negative and single-Mtv mice to evaluate the effects of endogenous viral superantigens on the T cell repertoire. J Exp Med. 1995 Nov 1;182(5):1493–1504. doi: 10.1084/jem.182.5.1493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Steinmetz M., Minard K., Horvath S., McNicholas J., Srelinger J., Wake C., Long E., Mach B., Hood L. A molecular map of the immune response region from the major histocompatibility complex of the mouse. Nature. 1982 Nov 4;300(5887):35–42. doi: 10.1038/300035a0. [DOI] [PubMed] [Google Scholar]
  29. Vidović D., Falcioni F., Siklodi B., Belunis C. J., Bolin D. R., Ito K., Nagy Z. A. Down-regulation of class II major histocompatibility complex molecules on antigen-presenting cells by antibody fragments. Eur J Immunol. 1995 Dec;25(12):3349–3355. doi: 10.1002/eji.1830251222. [DOI] [PubMed] [Google Scholar]
  30. Woods A., Chen H. Y., Trumbauer M. E., Sirotina A., Cummings R., Zaller D. M. Human major histocompatibility complex class II-restricted T cell responses in transgenic mice. J Exp Med. 1994 Jul 1;180(1):173–181. doi: 10.1084/jem.180.1.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Zamvil S., Nelson P., Trotter J., Mitchell D., Knobler R., Fritz R., Steinman L. T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. 1985 Sep 26-Oct 2Nature. 317(6035):355–358. doi: 10.1038/317355a0. [DOI] [PubMed] [Google Scholar]
  32. Zhang J., Markovic-Plese S., Lacet B., Raus J., Weiner H. L., Hafler D. A. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med. 1994 Mar 1;179(3):973–984. doi: 10.1084/jem.179.3.973. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES